BioAdvance
BioAdvance is a venture capital firm based in Philadelphia, United States. This profile covers what BioAdvance invests in, its typical stage and check size, and how founders can get in front of it in 2026.
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
- Investment focus
- Healthcare & BiotechBiotech & PharmaIoT & Connected Devices
- Location
- Philadelphia, United States
- Founded
- 2003
- Team size
- 1-10
- Investments
- 10
- Typical round
- $11M
How to pitch BioAdvance
The founders who hear back from BioAdvance lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Frequently Asked Questions
What does BioAdvance invest in?
BioAdvance focuses on Healthcare & Biotech, Biotech & Pharma and IoT & Connected Devices. Match your sector and stage before reaching out, then find similar active investors on Round Funded.
What is BioAdvance's typical check size?
BioAdvance's typical round is around $11M. Use it as a signal for whether your raise fits its stage.
How do I contact BioAdvance?
Unlock BioAdvance's verified email and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
